McElhaugh Michael J.

McElhaugh Michael J. is listed in filings as Interim President & CEO at Arbutus Biopharma Corporation. This profile follows SEC Form 4 activity through Feb 19, 2025, including sale activity. Recent filings connect the profile to Arbutus Biopharma Corporation (ABUS). The current snapshot covers public activity from Feb 5, 2025 to Feb 19, 2025. Reported amounts are shown as $78.1K to $2.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.